JRS offers an 8.9% yield and real estate exposure but faces pressure from high rates and limited upside versus peers like VNQ ...

Viking Therapeutics ' (NASDAQ: VKTX) shares could rise over the next year by as much as 165% at the midpoint according to ...

Plus, PIMCO's Robert Mead explains why the outlook for core bonds is looking particularly attractive due to high starting ...